Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association
Not that this has not been demonstrated before but to my surprise the questions on thyroid tumors and GLP-1 RA keep coming especially from non-endocrinologists This was a huge study that included a total of 460,032 users of GLP-1RAs, 717,792 users of SGLT2is, 2,055,583 users of DPP-4is, and 1,119,868 users of SUs GLP-1RA exposure was not associated with an increased risk of thyroid tumors compared with SGLT2is, DPP-4is, or SUs (meta-analysis: GLP-1RA vs
The most common side effects include nausea, constipation, bloating, reduced appetite, fatigue, and mild headaches
Quality, purity, and accurate labelling can vary significantly between manufacturers
Further potential of GLP-1 RAs Osteoarthritis Osteoarthritis (OA) is a condition where the entire joint undergoes wear and tear, leading to the loss of cartilage, swelling in the joint lining, and thickening of the bone under the cartilage, which may cause the formation of bone spurs